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Summary
Aurora B is the catalytic subunit of the chromosomal pas-
senger complex (CPC), which coordinatesmitotic processes
through phosphorylation of key regulatory proteins [1]. In
prometaphase, the CPC is enriched at the centromeres to
regulate the spindle checkpoint and kinetochore-microtu-
bule interactions. Centromeric CPC binds to histone H3
that is phosphorylated at T3 (H3T3ph) by Aurora B-stimu-
lated Haspin [2–5]. PP1/Repo-Man acts antagonistically to
Haspin and dephosphorylates H3T3ph at the chromosome
arms but is somehow prevented from causing a net dephos-
phorylation of centromeric H3T3ph during prometaphase [6,
7]. Here, we show that Aurora B phosphorylates Repo-Man at
S893, preventing its recruitment by histones. We also iden-
tify PP2A as a mitotic interactor of Repo-Man that dephos-
phorylates S893 and thereby promotes the targeting of
Repo-Man to chromosomes and the dephosphorylation of
H3T3ph by PP1. Thus, Repo-Man-associated PP1 and PP2A
collaborate to oppose the chromosomal targeting of Aurora
B. We propose that the reciprocal feedback regulation of
Haspin and Repo-Man by Aurora B generates a robust bista-
ble response that culminates in the centromeric targeting of
the CPC during prometaphase.
Results and Discussion
Aurora B Opposes the Targeting of Repo-Man to
Chromosomes
The chromosomal passenger complex (CPC) promotes its
own accumulation at centromeres during prometaphase
[1, 4]. This can be partially explained by the Aurora B-cata-
lyzed phosphorylation of Haspin, which stimulates its ability
to phosphorylate H3T3, thereby creating a docking site for
the CPC component survivin. However, the phosphatase
PP1/Repo-Man is an equally important regulator of mitotic
H3T3 phosphorylation and centromeric CPC targeting [6, 7].
Indeed, the loss of PP1/Repo-Man results in the spreading
of H3T3ph and Aurora B to the chromosome arms during
prometaphase, while an excess of this PP1 holoenzyme
causes the precocious loss of centromeric H3T3ph and Aurora
B. These data demonstrate that the activity of PP1/Repo-Man
must be tightly regulated during mitosis. This regulation in-
cludes not only the Cdk1-inhibited association of PP1 with
Repo-Man but also a poorly understood chromosomal target-
ing mechanism of Repo-Man [7–9]. We speculated that Aurora
B stimulates its own chromosomal targeting, not only by pro-
moting Haspin-mediated H3T3 phosphorylation but also by*Correspondence: mathieu.bollen@med.kuleuven.beopposing H3T3ph dephosphorylation through inhibition of
the chromosomal targeting of Repo-Man and associated PP1.
To study the subcellular distribution of endogenous Repo-
Man in U2OS osteosarcoma cells, we performed immunofluo-
rescence microscopy with an antibody against the C-terminal
residues 761–854 (see Figure S1A available online). Little or no
signal was detected after the small interfering RNA (siRNA)-
mediated knockdown of Repo-Man, attesting to the specificity
of the antibody. Consistent with previous observations [6–9],
Repo-Man showed a diffuse staining during prometaphase
and metaphase but was largely chromosome associated dur-
ing anaphase and telophase. Repo-Man sometimes seemed
to be excluded from prometaphase chromosomes (Fig-
ure S1B), but this is most likely due to the fixation procedure,
as Repo-Man was always enriched at chromosomes in deter-
gent-pretreated [6] or live prometaphase cells (Figure S1B).
To examine the role of Aurora B in the targeting of Repo-Man
to prometaphase chromosomes, we first made use of the
Aurora B inhibitors ZM447439 (Figure 1A) and hesperadin (Fig-
ure S1C). The inhibition of Aurora B in nocodazole-arrested
cells for 30 min resulted in a nearly exclusive chromosomal
targeting of endogenous Repo-Man. This retargeting effect
was not detected when the cells were preincubated with caly-
culin A (Figure 1A), a potent inhibitor of PP1, PP2A, and PP2A-
like phosphatases, indicating that the chromosomal targeting
of Repo-Man not only requires the inhibition of Aurora B but
also depends on a dephosphorylation event. The same obser-
vations were made for ectopically expressed EGFP-tagged
Repo-Man (Figure S1D). The ZM447439-induced chromo-
somal targeting of Repo-Man was also observed when noco-
dazole-arrested cells were kept in prometaphase with the
proteasome inhibitor AM114 (Figure S1E), indicating that this
effect was not due to a precocious mitotic exit resulting from
an override of the spindle-assembly checkpoint. ZM447439
treatment resulted in a loss of Aurora B from centromeres (Fig-
ure S1F), in accordance with previous findings [4, 10, 11], and
this correlatedwith chromosomal hypertargeting of Repo-Man
during prometaphase. As an independent approach to
examine the role of chromosome-associated Aurora B in the
recruitment of Repo-Man, we performed a knockdown of the
mitotic kinesin Mklp2, which is required for the translocation
of the CPC to the spindle midzone in anaphase [12]. Aurora B
remained associated with the chromosomes during anaphase
after the knockdown of Mklp2, and this prevented the associ-
ation of endogenous (Figure 1B) and ectopically expressed
EGFP-Repo-Man (Figure S1G) with the chromosomes. How-
ever, the mere addition of ZM447439 was sufficient to rescue
this phenotype (Figure 1B), confirming that Aurora B-mediated
phosphorylation prevents the recruitment of Repo-Man.
In further agreement with an inhibitory role of Aurora B in
the chromosomal targeting of Repo-Man, we found that
Repo-Manwas barely associatedwith bleomycin-induced lag-
ging telophase chromosome arms that were located in close
proximity to Aurora B at the spindle midzone (Figure 1C).
This is in accordance with a report showing that the midzone
activation of Aurora B creates an intracellular phosphorylation
gradient, with the highest kinase activity at and close to the
midzone [13].
Figure 1. Aurora B Inhibits the Chromosomal Targeting of Repo-Man
(A) Confocal images of fixed nocodazole-arrested U2OS cells after incubation for 30min with vehicle or 2 mMZM447439 (ZM), as such or after preincubation
of the cells for 30minwith 25 nM calyculin A. Scale bars represent 5 mm. The numbers refer to the percentage of cells with the illustrated phenotype in at least
98 cells in each condition.
(B) U2OS cells were transfected with control orMklp2 siRNAs. In one condition, theMklp2 knockdownwas combinedwith an incubation for 30minwith 2 mM
ZM447439. Repo-Man, Aurora B, and DNA were visualized in anaphase cells, which were obtained by a 90 min release from a nocodazole arrest. DIC, dif-
ferential interference contrast. Scale bars represent 5 mm. The numbers refer to the percentage of cells with the illustrated phenotype in at least 86 cells in
each condition.
(C) Nocodazole-arrested U2OS cells expressing EGFP-Repo-Man were treated for 60 min with 10 mM bleomycin. Subsequently, the cells were incubated
without nocodazole and bleomycin for 2 hr before fixation. Confocal images were taken, and the EGFP/DNA ratio of the indicated chromosome regions
was plotted. Scale bars represent 5 mm.
(D) The indicated EGFP-tagged Repo-Man fragments were expressed in U2OS cells and scored for their ability to associate with anaphase chromosomes,
which were obtained by a 60 min release from a nocodazole block. In addition, the fusions were examined for their association with prometaphase chro-
mosomes after a 30 min preincubation with 2 mM ZM447439 (ZM).
(E) Protein conservation analysis of Repo-Man with the National Center for Biotechnology Information’s Protein Basic Local Alignment Search Tool. The
alignment scores are color coded. The positions of domains A and B are indicated below.
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B opposes the chromosomal targeting of Repo-Man, we have
used deletion mutagenesis to map the fragments of Repo-
Man that are required for its chromosomal targeting and
that mediate the sensitivity to ZM447439 (Figures 1D and
S1H). We started from an EGFP fusion of Repo-Man-(403–
1043). This Repo-Man fragment lacks the N-terminal binding
sites for importin b and PP1, but it is still properly targeted to
anaphase chromosomes [7]. N- and C-terminal deletions
identified two Repo-Man domains, comprising residues
550–600 (domain A) and 890–925 (domain B), that were
essential for its chromosomal targeting during anaphase.
Both domains are phylogenetically conserved in vertebrates
(Figure 1E). Intriguingly, domain A was not required for the
ZM447439-induced chromosomal targeting of Repo-Man
during prometaphase (Figure 1D), indicating that domain B
harbors both the chromosome-binding site and the inhibitory
Aurora B site.Phosphorylation by Aurora B Abolishes the Binding of
Repo-Man to Histones
The ZM447439-sensitive domain B of Repo-Man only contains
S893 as a consensus Aurora B phosphorylation site [14] that is
conserved in vertebrates (Figure 2A). Bacterially expressed
and purified His-tagged Repo-Man-(865–925), which includes
domain B, could be radioactively phosphorylated by purified
GST-AuroraB-INCENP (Figure 2B). However, virtually no phos-
phorylationwas detectedwith the S893Dmutant, showing that
S893 is an in vitro phosphorylation site for Aurora B. To explore
whether S893 is also phosphorylated in intact cells, we raised
a phosphoepitope-specific antibody. The affinity-purified anti-
body revealed a clear phosphorylation of EGFP-Repo-Man
that was immunoprecipitated from nocodazole-arrested
U2OS cells (Figure 2C). However, no phosphorylation of
Repo-Man at S893 was detected in nonsynchronized cells.
Neither was a phosphorylation detected in nocodazole-ar-
rested cells that had been preincubated with ZM447439 or
Figure 2. Aurora B-Mediated Phosphorylation of Repo-Man at S893 Disrupts Its Interaction with Histones and Hampers the Dephosphorylation of H3T3ph
(A) Conservation of a fragment of domain B of Repo-Man.
(B) His-Repo-Man-(865–925) wild-type (WT) or the corresponding S893D mutant were phosphorylated with GST-AuroraB-INCENP. The phosphorylation
was visualized by autoradiography. The Coomassie staining of the substrates serves as a loading control.
(C) U2OS cells were transfected with full-length EGFP-Repo-Man WT or S893A. EGFP traps were performed from lysates of mitotic shake-off (mitotic) or
nonsynchronized (nonsync) cells, pretreated or not with 2 mM ZM447439 (ZM). The figure shows immunoblots with antibodies against EGFP or phos-
pho-S893 of Repo-Man (RM-pS893).
(legend continued on next page)
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1139that expressed the S893A mutant of Repo-Man. Collectively,
these data identify S893 of Repo-Man as an Aurora B phos-
phorylation site in prometaphase cells.
The phosphomimicking S893D mutant of EGFP-tagged
Repo-Man-(403–1023) failed to target to prometaphase chro-
mosomes in the presence of ZM447439 (Figure 2D) and was
not associated with anaphase chromosomes (Figure 2E). Like-
wise, the S893D mutant of full-length EGFP-Repo-Man
showed no enrichment on prometaphase chromosomes in
live cells (Figure 2F). These data represent good evidence
that the Aurora B-mediated phosphorylation of S893 prevents
the chromosome targeting of Repo-Man. Since the S893D
mutant of Repo-Man cannot be targeted to chromosomes,
this enabled us to explore the relevance of the chromosome
targeting of Repo-Man for the dephosphorylation of H3T3ph
by associated PP1. Consistent with our previous data [6], the
ectopic expression of EGFP-Repo-Man resulted in the hypo-
phosphorylation of centromeric H3T3 in nocodazole-arrested
cells (Figures 2G and 2H). However, this decreased level of
H3T3ph was not detected after the expression of the S893D
mutant of Repo-Man. Conversely, the knockdown of endoge-
nous Repo-Man caused the hyperphosphorylation and
spreading of H3T3 in prometaphase cells. The latter effect
could be rescued by the expression of siRNA-resistant
EGFP-Repo-Man, but not by the expression of the corre-
sponding S893D mutant. Similar rescue data were obtained
for cells in anaphase (Figure S2A). Thus, the dephosphoryla-
tion of H3T3ph by PP1/Repo-Man is critically dependent on
the chromosome targeting of Repo-Man.
To identify the proteins that mediate the binding of Repo-
Man to chromosomes, we performed traps of EGFP fusions
of Repo-Man-(403–1023) that were expressed in HEK293T
cells. The traps were analyzed by Coomassie staining after
SDS-PAGE (Figure 2I). These studies revealed that wild-type
Repo-Man, but not the S893D mutant, coprecipitated with
nearly stoichiometric amounts of polypeptides that migrated
like the core histones. Their identity as core histones was
confirmed by immunoblotting (Figure S2C) and is consistent
with a previous study that identified histones H2B and H3 in
immunoprecipitates of Repo-Man [7]. Deletion mutagenesis
revealed that the binding of Repo-Man to histones was de-
pendent on residues 890–925, corresponding to domain B
(Figure 2I). We have considered the possibility that the chro-
mosome binding of Repo-Man is also (partially) mediated by
DNA. However, Repo-Man does not have a recognizable nu-
cleic acid-binding domain. Also, the prior digestion of the
EGFP trap with the nuclease benzonase hydrolyzed the copre-
cipitated DNA but did not abolish the interaction of EGFP-
Repo-Man-(403–1023) with the core histones (Figure S2D). In
conclusion, these data suggest that the Aurora B-mediated
phosphorylation of Repo-Man at S893 prevents its binding to
core histones.(D) EGFP-Repo-Man-(403–1023) WT or S893D was expressed in nocodazole-a
without 2 mM ZM447439 (ZM) for 30 min. The numbers refer to the percentage
(E) Confocal images of fixed U2OS cells in anaphase and expressing EGFP-R
cells with the illustrated phenotype in at least 60 cells in each condition.
(F) Confocal live images in prometaphase-arrested U2OS cells expressing full-le
cells with the illustrated phenotype in at least 34 cells in each condition.
(G) EGFP, H3T3ph, and DNA were visualized in fixed prometaphase-arrested
EGFP-Repo-Man WT or S893D. The same images were also obtained after the
(H) Quantification of the H3T3ph/DNA ratios for the conditions illustrated in (G
(I) Cell lysates from HEK293T cells expressing EGFP fusions of the indicated Re
the EGFP fusions were trapped and processed for Coomassie staining after SThe Chromosome Targeting of Repo-Man Depends on
Associated PP2A
To obtain more information on the role of domain A (residues
550–600) in the chromosomal targeting of Repo-Man (Fig-
ure 1D), we identified proteins that coprecipitated with
EGFP-Repo-Man-(403–1023) from lysates of nocodazole-
arrested HEK293T cells. This led to the mass-spectrometric
identification of the catalytic subunit of protein phosphatase
PP2A (PP2A-C) as a novel mitotic component of the Repo-
Man complex (Figure S2B). The presence of PP2A-C was inde-
pendently confirmed by immunoblotting of EGFP-Repo-Man
traps (Figure S2C) and is in accordance with a recent mass-
spectrometric analysis of the Repo-Man interactome [8].
PP2A-C also coprecipitated with the S893D mutant of Repo-
Man (Figure S2C), indicating that its recruitment is indepen-
dent of chromosome targeting. To examine whether PP2A is
relevant for the chromosome targeting of Repo-Man, we per-
formed knockdown experiments of PP2A-Ca, the major iso-
form of the catalytic subunit. In cells with a strongly reduced
expression of PP2A-Ca, Repo-Man-(550–1023) was no longer
associated with anaphase chromosomes (Figure 3A). These
results hinted at a stimulatory role of PP2A in the chromosome
targeting of Repo-Man and prompted us to explore in more
detail the nature and function of Repo-Man-associated PP2A.
PP2A holoenzymes consist of a catalytic C subunit, a scaf-
folding A subunit, and a variable regulatory B subunit [15].
Immunoblot experiments demonstrated that EGFP-Repo-
Man was associated with the C and A subunits of PP2A, as
well as with all tested isoforms of the regulatory B56 subunit
(Figure 3B). Deletion mutagenesis revealed that residues
550–600, corresponding to domain A, were required for the
binding of all three PP2A subunits. Intriguingly, domain A of
Repo-Man comprises a region that is conserved in vertebrates
(Figure 3C) and is similar to a recently identified direct B56-
binding sequence in the kinetochore protein BubR1 [16, 17].
This sequence will be denoted here henceforth as the LSPI-
motif, after its most conserved residues (amino acids 590–
593 of human Repo-Man). The synthetic peptide Repo-Man-
(581–599), comprising the LSPI-motif with its flanking se-
quences and coupled via BSA to CNBr-activated Sepharose,
could be used to bind the PP2A-B56 complex from U2OS
cell lysates (Figure 3D), confirming the presence of a PP2A-
binding motif. In contrast, PP2A was not retained by BSA-
Sepharose. Also, the deletion of the LSPI-motif and its flanking
residues (D585–599) or the mutation of the LSPI-motif in one
(I593A or I593F) or two residues (S591A and I593A, henceforth
referred to as the LAPA mutant) abolished the binding of
EGFP-Repo-Man-(550–1023) to all three PP2A subunits (Fig-
ure 3E). We have subsequently used some of these binding
mutants to delineate the contribution of PP2A to the chromo-
some targeting of Repo-Man. Ectopically expressed EGFP-
Repo-Man-(550–1023) with a deleted or mutated LSPI-motifrrested U2OS cells. Confocal images were taken after preincubation with or
of cells with the illustrated phenotype in at least 90 cells in each condition.
epo-Man-(403–1023) WT or S893D. The numbers refer to the percentage of
ngth EGFP-Repo-ManWT or S893D. The numbers refer to the percentage of
U2OS cells in control conditions or after the expression of siRNA-resistant
knockdown of Repo-Man.
). The results represent means 6 SEM for 16–22 cells in each condition.
po-Man fragments were treated with micrococcal nuclease. Subsequently,
DS-PAGE.
Figure 3. The Chromosome Targeting of Repo-Man Depends on Associated PP2A
(A) Confocal images of fixed U2OS anaphase cells expressing EGFP-Repo-Man-(550–1023) 48 hr after transfection with control or PP2A-Ca siRNAs.
(B) HEK293T cells expressing the indicated EGFP-Repo-Man fusions were nocodazole arrested. The micrococcal-nuclease-treated cell lysates were used
for EGFP trapping.
(C) Sequence conservation of a fragment of domain A of Repo-Man. Also shown is the phylogenetic conservation of the PP2A-B56-binding region of BubR1.
(D) The synthetic peptide Repo-Man-(581–599) was coupled to BSA. BSA (control) or peptide-linked BSA (peptide) was subsequently linked to CNBr-acti-
vated Sepharose-4B and incubated for 30 min with U2OS cell lysates. The PP2A subunits were visualized by immunoblotting.
(E) HEK293T cells were transfected with EGFP-Repo-Man-(550–1023) WT or the indicated PP2A-binding mutants. The micrococcal-nuclease-treated cell
lysates from nocodazole-arrested cells were used for EGFP trapping. The lysates and traps were processed for immunoblotting.
(F) Confocal images of U2OS anaphase cells expressing EGFP-Repo-Man-(550–1023) WT or the indicated PP2A-binding mutants.
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as an interactor of the LSPI-motif and show that Repo-Man-
associated PP2A is essential for its chromosomal targeting.
PP2A and Aurora B Antagonistically Regulate the
Phosphorylation of S893
Since the Aurora B-mediated phosphorylation of Repo-Man at
S893 hampers its binding to histones, and since PP2A is
required for the chromosomal targeting of Repo-Man, this
suggested that Repo-Man-associated PP2A acts as a S893
phosphatase. This hypothesis is consistent with our observa-
tion that the chromosomal targeting of Repo-Man induced by
the inhibition of Aurora B can be rescuedwith the phosphatase
inhibitor calyculin A (Figure 1A). To further test this model, we
radioactively phosphorylated bacterially expressed His-
tagged Repo-Man-(865–925) at S893 by GST-AuroraB-
INCENP (Figure 2B) and subjected it to dephosphorylation
by PP2A. As a source of PP2A, we used an immunoprecipitate
of EGFP-Repo-Man-(550–1023), which lacks the PP1-binding
site (Figure 4A). This immunoprecipitate caused a nearly com-
plete dephosphorylation of S893, which could be blocked with
10 nM okadaic acid, a concentration that selectively inhibits
PP2A. However, no dephosphorylation was detected with an
immunoprecipitate of a PP2A-binding mutant of this Repo-
Man fusion.To delineate the relative contribution of PP1 and PP2A to the
dephosphorylation and chromosome targeting of Repo-Man
in prometaphase cells, we made use of PP1-binding (RATA)
and PP2A-binding (LAPA) mutants of full-length Repo-Man.
Only the LAPA and combined RATA and LAPA mutants were
hyperphosphorylated at S893 in nocodazole-arrested cells,
as compared to the wild-type protein (Figure 4B), suggesting
that this residue is selectively dephosphorylated by PP2A dur-
ing prometaphase. Consistent with this notion, only the LAPA
mutants showed a deficient targeting to prometaphase chro-
mosomes in live cells (Figure 4C). In further agreement with
an antagonistic regulation of Repo-Man by Aurora B and
PP2A, the LAPA mutants showed a decreased sensitivity to
ZM447439-induced chromosome targeting (Figure 4D). This
altered sensitivity to ZM447439 was not seen with the RATA
mutants. Since the chromosome targeting of Repo-Man is
essential for the dephosphorylation of H3T3ph (Figure 2G),
this implies that a PP2A-binding mutant of Repo-Man should
show a deficient H3T3ph dephosphorylation. Indeed, the
ectopic expression of the LAPA mutant did not cause the hy-
pophosphorylation of H3T3 during prometaphase, as detected
after expression of wild-type Repo-Man (Figures 4E and 4F).
Moreover, the LAPA mutant did not rescue the hyperphos-
phorylation of H3T3 induced by the knockdown of endoge-
nous Repo-Man. Taken together, our data demonstrate that
PP2A acts antagonistically to Aurora B by dephosphorylating
Figure 4. PP2A and Aurora B Antagonistically Regulate the Chromosome Targeting of Repo-Man
(A) U2OS cells were transfected with EGFP-Repo-Man-(550–1023)-S893D or the corresponding LAPA mutant. Micrococcal-nuclease-treated cell lysates
prepared from cells collected by mitotic shake-off were used for EGFP traps. The traps were used to dephosphorylate bacterially expressed His-tagged
Repo-Man-(865–925) that had been phosphorylated with GST-AuroraB-INCENP. In one condition, okadaic acid (OA) was added. After incubation for
40 min at 30C, the dephosphorylation reaction was arrested with SDS-sample buffer. The figure shows the Coomassie staining and autoradiograph of
the substrate after SDS-PAGE, as well as the amount of added EGFP fusion and PP2A.
(B) U2OS cells were transfected with full-length EGFP-Repo-ManWT or the indicated RATA or LAPAmutants and collected bymitotic shake-off. EGFP traps
of the micrococcal-nuclease-pretreated cell lysates were analyzed by immunoblotting. RM-pS893 refers to phosphorylation of Repo-Man at S893.
(C) Confocal images of nocodazole-arrested U2OS cells after the expression of full-length EGFP-Repo-Man WT or the indicated phosphatase-binding mu-
tants. Scale bars represent 5 mm.
(D) Nocodazole-arrested U2OS cells expressing full-length EGFP-Repo-Man WT or the indicated mutants were incubated for 30 min with ZM447439 (ZM)
before fixation. DNAwas stained with DAPI. The figure shows the percentage of cells where EGFP-Repo-Man was chromosome associated (means6 SEM;
three independent experiments, >227 cells per data point).
(E) EGFP, H3T3ph, and DNA images in fixed, prometaphase-arrested U2OS control cells or cells that expressed siRNA-resistant EGFP-Repo-Man WT or
LAPA mutant. The images were also obtained after the knockdown of Repo-Man.
(F) Quantification of the H3T3ph/DNA ratio for the conditions illustrated in (E). The results represent means 6 SEM for 16–22 cells per condition.
(G)Model of the centromeric targeting of the CPCduring prometaphase. The initiation of centromeric CPC targeting stems fromAurora B-stimulated recruit-
ment of Bub1 to the kinetochores, which phosphorylates histone H2A at T120 (H2AT120ph), a docking site for shugoshin, which directly binds to the CPC.
This small CPC pool stimulates Haspin-mediated phosphorylation of histone H3 at T3 (H3T3ph), resulting in an amplification of CPC recruitment at the
centromeres. In addition, the CPC phosphorylates Repo-Man at S893, which prevents its recruitment to histones and dephosphorylation of H3T3ph by
associated PP1.
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dephosphorylation of H3T3ph by PP1/Repo-Man. The possi-
bility cannot be excluded that Repo-Man-associated PP2A
also directly contributes to the dephosphorylation of H3T3ph
during prometaphase. However, its contribution is likely to
be minor, since a prometaphase immunoprecipitate of the
RATA mutant of Repo-Man could not dephosphorylate
H3T3ph, and since mutation of the PP1-docking site alleviated
the hypophosphorylation of H3T3 induced by the overexpres-
sion of Repo-Man [6].
Conclusions
We have demonstrated here that the chromosomal targeting
of Repo-Man is antagonistically regulated by Aurora B and
PP2A. The balance between these opposing enzymes regu-
lates the phosphorylation of Repo-Man at S893, which is a
negative determinant of histone binding. Until the end of
metaphase, Aurora B is enriched at the chromosomes and
opposes the recruitment of Repo-Man by phosphorylation
of S893. This may explain why Repo-Man is only partially
chromosome associated in early mitosis. The translocation
of the CPC to the spindle midzone in anaphase reduces its
ability to phosphorylate Repo-Man and correlates with an
increased chromosomal targeting of Repo-Man. However, it
is well established that the targeting of Repo-Man to prome-
taphase chromosomes is highly dynamic [8, 9, 18], indicating
that the balance between Aurora B and Repo-Man-associ-
ated PP2A is tightly regulated. This is reminiscent of the
antagonism between Aurora B and BubR1-associated B56-
PP2A, which dynamically regulates the phosphorylation of
Aurora B substrates at the kinetochore and is essential to
generate stable and correct kinetechore-microtubule attach-
ments [16, 17, 19]. Here, we have only explored the impor-
tance of the chromosome targeting of Repo-Man for the
dephosphorylation of H3T3. However, Repo-Man has also
established functions in chromosome movement [20], chro-
mosome decondensation [21], and nuclear reassembly [7],
but the relevant substrates remain to be identified. We pro-
pose that the chromosome targeting of Repo-Man also con-
tributes to the dephosphorylation of other mitotic substrates.
Since Repo-Man emerges from our studies as a mitotic scaf-
fold for both PP1 and PP2A, it will be important to under-
stand how these phosphatases are functionally integrated
and regulated.
The double-negative feedback regulation from Aurora B to
Repo-Man is likely to be an important determinant of the
centromeric targeting of the CPC during prometaphase and
metaphase, in particular because it coincides with a positive
feedback loop from Aurora B to Haspin [4]. Reciprocal feed-
back regulation of opposing enzymes is indeed well known
to generate robust, bistable responses [22]. The centromeric
targeting of the CPC also involves its binding to shugoshin
via histone H2A that is phosphorylated at T120 by protein ki-
nase Bub1 [23, 24]. The targeting of Bub1 to the kinetochores
is stimulated by Aurora B, providing yet another positive feed-
back loop that autoregulates centromeric CPC targeting. How-
ever, the number of shugoshinmolecules inmitotic cells is very
small compared to that of Aurora B [25], and H2A T120ph
already accumulates in prophase [23, 24]. Hence, the shu-
goshin-mediated recruitment of the CPC is likely to serve
only as an initial trigger, to recruit some CPC complexes to
the centromeres that then autonomously promote the recruit-
ment of additional CPCs via reciprocal feedback regulation of
Haspin and Repo-Man, culminating in the exclusivecentromeric accumulation of the H3T3ph-type docking site
(Figure 4G).
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